Arno Therapeutics, Inc.
Arno Therapeutics, Inc. (ARNI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
arni · pe ratio · data through Dec 31, 2015
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Arno Therapeutics, Inc. (ARNI) measures how much investors pay for each dollar of the company's trailing earnings. ARNI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.57.
Source: FMP · /ratios-ttm · /analyst-estimates · 2015-12-31
PE Ratio History
2003 – 2015 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Arno Therapeutics, Inc.You ARNI | $0M | N/A | — | -$0.57 |
 Ampio Pharmaceuticals, Inc. AMPE | $0M | N/A | — | -$10.67 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 Baudax Bio, Inc. BXRXQ | $0M | N/A | — | -$177.30 |
 Calithera Biosciences, Inc. CALA | $0M | N/A | — | -$3.78 |
 Innovation1 Biotech Inc. IVBT | $0M | N/A | — | -$0.30 |
 Kaleido Biosciences, Inc. KLDO | $0M | N/A | — | -$2.16 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2015-12-31Latest FY2015 | — | $-0.57 | — | |
2014-12-31 FY2014 | 1.75x | $0.38 | — | |
2013-12-31 FY2013 | — | $-7.75 | — | |
2012-12-31 FY2012 | — | $-4.57 | — | |
2011-12-31 FY2011 | — | $-1.90 | — | |
2010-12-31 FY2010 | — | $-1.58 | — | |
2009-12-31 FY2009 | — | $-2.72 | — | |
2008-12-31 FY2008 | — | $-6.45 | — | |
2007-12-31 FY2007 | 535.55x | $0.03 | — | |
2006-12-31 FY2006 | — | $-0.07 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Arno Therapeutics, Inc. (ARNI) measures how much investors pay for each dollar of the company's trailing earnings. ARNI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.57.
Frequently asked questions
ARNI pe ratio · 6 questionsARNI's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.00 and TTM EPS of -$0.57. Data sourced from Financial Modeling Prep via ARNI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Arno Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08